Adding carboplatin to adjuvant chemotherapy improved survival in early‐stage triple‐negative breast cancer

Documenti analoghi

• Adding adjuvant nivolumab improved disease‐free survival for patients with high‐risk locally advanced HNSCC
  di: Leah Lawrence
  Pubblicazione: (2025)
• Adjuvant chemoradiation offers minimal survival improvements over radiation alone in intermediate‐risk, early cervical cancer
  di: Leah Lawrence
  Pubblicazione: (2026)
• T‐DXd shows benefit over T‐DM1 in patients with early breast cancer
  di: Leah Lawrence
  Pubblicazione: (2026)
• Switching to camizestrant prolonged PFS for patients with ER‐positive, HER2‐negative advanced breast cancer
  di: Leah Lawrence
  Pubblicazione: (2025)
• Genomic and transcriptomic profiling of pre‐ and postneoadjuvant chemotherapy triple negative breast cancer tumors
  di: Tomomi Nishimura, et al.
  Pubblicazione: (2024)